Organon

Beyond inadequate access to reproductive healthcare, outside influences, stigma, and misinformation can shape a woman’s understanding of her sexual and reproductive health. Our team visited select community health clinics in contraceptive deserts to understand these influences and see how each clinic is working to expand health education. #HerPlanHerPower #WomensHealth #ReproductiveHealth

Endometriosis affects about 10% of reproductive-age women globally, but it’s often misdiagnosed and misunderstood. This condition isn’t just about pain–it’s missed workdays, financial burdens, and the emotional effect of feeling unheard. As a company focused on addressing health conditions that are unique to women, affect her disproportionately or impact her differently, we’ll continue to bring awareness, investment, and scientific and commercial expertise to the healthcare ecosystem supporting the health of women. #WomensHealth #Endometriosis #EndometriosisActionMonth #EndometriosisAwareness

Research has shown that women are more likely to experience atypical heart attack symptoms, and younger women are more likely to be misdiagnosed by a doctor. Organon META (Middle East, Turkey & Africa)'s Mis(s)diagnosed campaign highlights these overlooked symptoms and the medical gender data gap. By educating and spreading awareness, we aim to help reduce misdiagnosis and improve heart health outcomes. Watch our video to learn more. Together, Organon is committed to advancing the health of women everywhere and creating a brighter future for her.?? #HeartHealth #WomensHealth #CardiovascularDisease

Caring for a child with eczema can have its fair share of challenges. Watch as Jaylin shares her journey in navigating her daughter’s eczema diagnosis and how finding education, support, and community helped them both thrive. #EczemaAwareness #Eczema #Dermatology

Board-certified OB/GYN, Dr. Christine Greves, is here to say ‘she listens and she doesn’t judge’, especially when it comes to helping women understand endometriosis. Addressing misconceptions may help improve care and close the women’s health gap. We’ll continue to bring awareness, investment, and scientific and commercial expertise to the healthcare ecosystem supporting the health of women. #WomensHealth #Endometriosis #EndometriosisActionMonth #EndometriosisAwareness

Felicia Bisaro, M.S. a member of the External Communications team at Organon, takes us behind the scenes at the 2025 American Academy of Dermatology (AAD) Annual Meeting. Check out some of the highlights from her day learning from industry leaders in dermatology and recognizing the announcement of Organon’s late-breaking analysis of Phase 3 data for our recently approved topical therapy for atopic dermatitis (eczema). #AAD2025 #Eczema #AtopicDermatitis #Dermatology

At Organon, we're dedicated to addressing conditions that disproportionately impact women, like migraine, the leading cause of disability for women aged 15-49 worldwide. Despite its potentially debilitating symptoms, migraine may remain a silent struggle due to stigma and misunderstanding. We're excited to join the Migraine Friendly Workplace initiative by the EMHA- European Migraine and Headache Alliance to help raise awareness of migraine and its impact in the workplace, and to provide further resources and support to our employees. Learn more about migraine: https://ogn.llc/6003qVuHl Pictured: Enrica Buccione, Flavia Binetti, Organon Italia, Elena Ruiz de la Torre GdB, EMHA, Krzysztof (Kris) Wojciechowski, Organon #Migraine #MigraineAwareness #TheMigraineMovement

Improving the health of women can have positive impacts on families, surrounding communities, and the economy. At Organon, we seek to understand what prevents women from prioritizing their own healthcare -- and this informs our investments in innovation, improved access and expanded choice for her. Hear more about the issues some women face and ways to address potential barriers to care.? #WomensHealth #ReproductiveHealth Video: Kevin Ali, Caroline Weber, Michael Dotson, Asheena Kuhn, Rachel Gotip, MSN, APRN, WHNP-BC, Jatu Boikai MSN, RNC-OB, C-EFM, CLC, Palak J., Desiree Norwood

Kaisa Illikainen, an Associate Principal Scientist in Medicinal Chemistry at Organon R&D Finland, is helping transform the way we understand and research conditions that are unique to women, like polycystic ovary syndrome (PCOS) and endometriosis. Driven by a lifelong passion for chemistry and biology, Kaisa is focused on turning complex science into potential solutions. Her research is dedicated to uncovering new ways to help address the unmet needs of women whose lives are impacted by these conditions. Her efforts are in line with Organon’s mission to find solutions that help support and empower women to live healthier, fuller lives. Learn more about her journey and the impact she has made at Organon: https://ogn.llc/6045quyBX #MindsBehindTheScience #WomenInScience #PCOS #Endometriosis #WomensHealth

At Organon, we are sparking collective action to deliver a new era in healthcare that empowers women globally. Our teams around the world come together to inspire and create educational initiatives and community outreach, unique partnerships to approach access to healthcare – all addressing the distinctive needs of their community and culture. In 2025, we’ll showcase how collaboration and outreach is helping to create a brighter future for women and their surrounding communities. Stay tuned! Video: Organon META (Middle East, Turkey & Africa), Organon Korea, Organon Italia, Organon South Africa, Organon Brasil, Organon México, Organon Latam, Organon Russia